Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.07 +0.05 (+4.41%)
As of: Nov 11, 2026 · 11:45 AM EST

Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021)

Updated

Cardiol Therapeutics (CRDL) posted Depreciation & Amortization - Total of $27,261 for Q2 2021, up 4.0% from $26,206 a year earlier.

Analysis

Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cardiol Therapeutics 102.26 Mn 40.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 27,261.30
Jun 30, 2020 26,206.39
API Access

Cardiol Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=CRDL&period=max&api_key=YOUR_API_KEY